Endometriozis Gelişiminde Kök Hücre Teorisi
Özet
Endometriozis, uterus dışında yerleşen ve fonksiyon gösteren endometrial dokunun neden olduğu kronik bir hastalıktır. Üreme çağındaki kadınların %10-15'ini etkileyen bu durum, şiddetli pelvik ağrı, dismenore, disparoni ve infertilite gibi semptomlarla ortaya çıkar. Hastalığın etyolojisi uzun yıllardır tartışılmakta ve retrograd menstruasyon ile metaplazi teorileri öne sürülse de, bu yaklaşımlar endometriotik lezyonların neden sadece bazı kadınlarda geliştiğini ve farklı bölgelerde oluştuğunu tam olarak açıklayamamaktadır.
Son dönemde öne çıkan kök hücre teorisi, endometriozisin hem endometrial hem de kemik iliği kaynaklı kök hücreler tarafından desteklendiğini ileri sürer. Endometrial kök hücrelerin anormal proliferasyonu, ektopik lezyonların oluşumuna yol açabilirken, bu hücrelerin inflamasyon ve hormonal sinyallerle aktive olup ektopik dokulara göç etmesi lezyonların farklı bölgelerde yerleşimini açıklayabilir. Kemik iliği kök hücreleri de inflamasyon bölgelerine göç ederek endometriotik lezyonların başlangıcına katkıda bulunabilir.
Kök hücrelerin endometriozis üzerindeki rolü, sadece hücresel düzeyde değil, aynı zamanda moleküler mekanizmalar üzerinden de incelenmektedir. Bu hücreler, proliferasyon, invazyon ve anjiyogenez süreçlerini destekleyerek lezyonların büyümesine ve yayılmasına katkıda bulunur. Ayrıca, kök hücreler, salgıladıkları sitokinler ve büyüme faktörleriyle immün yanıtı baskılayarak lezyonların immün sistemden kaçmasını sağlar.
Kök hücre teorisi, endometriozis tedavisinde yeni yaklaşımlar için önemli bir potansiyel sunmaktadır. Kök hücrelerin moleküler ve genetik özelliklerinin hedeflenmesiyle lezyonların büyümesi durdurulabilir ve doku yenilenmesi sağlanabilir. Bu da, endometriozis tedavisinde minimal invaziv stratejiler geliştirilmesine imkan tanıyabilir.
Endometriosis is a chronic disease caused by endometrial tissue that is located and functions outside the uterus. This condition affects 10-15% of women of reproductive age and manifests with symptoms such as severe pelvic pain, dysmenorrhea, dyspareunia, and infertility. Although the etiology of the disease has been debated for many years, and theories such as retrograde menstruation and metaplasia have been proposed, these approaches do not fully explain why endometriotic lesions develop only in some women and in different locations.
The stem cell theory, which has recently gained attention, suggests that endometriosis is supported by both endometrial and bone marrow-derived stem cells. While abnormal proliferation of endometrial stem cells may lead to the formation of ectopic lesions, the activation of these cells by inflammation and hormonal signals and their migration to ectopic tissues may explain the diverse localization of lesions. Bone marrow-derived stem cells can also migrate to inflammation sites, contributing to the initiation of endometriotic lesions.
The role of stem cells in endometriosis is being investigated not only at the cellular level but also through molecular mechanisms. These cells contribute to the growth and spread of lesions by supporting processes such as proliferation, invasion, and angiogenesis. Furthermore, stem cells suppress the immune response through the cytokines and growth factors they secrete, allowing lesions to evade the immune system.
The stem cell theory offers significant potential for new approaches in the treatment of endometriosis. Targeting the molecular and genetic properties of stem cells could halt lesion growth and promote tissue regeneration, which may enable the development of minimally invasive strategies for endometriosis treatment.
Referanslar
Halme J, Hammond MG, Hulka JF, et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstetrics and Gynecology. 1984;64(2):151-154.
Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: The first 10 years. Human Reproduction Update. 2016;22(2):137-163. doi:10.1093/humupd/dmv051
Klemmt PAB, Starzinski-Powitz A. Molecular and cellular pathogenesis of endometriosis. Current Women's Health Reviews. 2018;14(2):106-116. doi:10.2174/1573404814666181122110906
Banas A, Teratani T, Yamamoto Y, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007;46(1):219-228. doi:10.1002/hep.21654
Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Annals of the New York Academy of Sciences. 2008;1127:106-115. doi:10.1196/annals.1434.012
Masuda H, Anwar SS, Buhring HJ, et al. A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplantation. 2012;21(10):2201-2214. doi:10.3727/096368911X627350
Gargett CE, Schwab KE, Zillwood RM, et al. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biology of Reproduction. 2009;80(6):1136-1145. doi:10.1095/biolreprod.108.075226
Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrial regeneration and pathogenesis of endometriosis. Biology of Reproduction. 2007;76(5):837-845. doi:10.1095/biolreprod.106.055129
Maruyama T, Yoshimura Y. Stem cell theory for the pathogenesis of endometriosis. Gynecologic and Obstetric Investigation. 2012;74(4):243-249. doi:10.1159/000343690
Sasson IE, Taylor HS. Stem cells in the pathogenesis of endometriosis. Annals of the New York Academy of Sciences. 2008;1127:106-115. doi:10.1196/annals.1434.012
Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Human Reproduction Update. 2007;13(4):331-342. doi:10.1093/humupd/dmm012
Zeitvogel A, Baumann R, Starzinski-Powitz A. Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new mouse model. The American Journal of Pathology. 2001;159(5):1839-1852. doi:10.1016/S0002-9440(10)63033-6
Ding DC, Chu TY, Hung WT, et al. Human endometrial mesenchymal stem cells as a cell source for the regeneration of injured uterine endometrium. Journal of Clinical Medicine. 2018;7(2):11. doi:10.3390/jcm7020011
Santamaria X, Massasa EE, Feng Y, et al. Derivation of insulin-producing beta cells from human endometrial mesenchymal stem cells and amniotic epithelial cells. PLoS One. 2011;6(10) . doi:10.1371/journal.pone.0026099
Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biology of Reproduction. 2004;70(6):1738-1750. doi:10.1095/biolreprod.103.024109
Maruyama T, Masuda H, Ono M, et al. Stem cell-like differentiation potentials of endometrial side population cells as revealed by single-cell RNA sequencing. PLoS One. 2018;13(10). doi:10.1371/journal.pone.0205604
Wang XQ, Krupin T, Peña JD, et al. Transforming growth factor-beta 2 promotes transdifferentiation and fibronectin expression of retinal pigment epithelial cells in vitro. Current Eye Research. 1999;19(6):510-521. doi:10.1076/ceyr.19.6.510.5287
Tang Y, Gargett CE. Stem cell research in human reproduction: A current overview. Reproductive BioMedicine Online. 2016;32(1):5-13. doi:10.1016/j.rbmo.2015.09.001
Sakr S, Naftalin J, Hoo W, et al. Bone marrow stem cells in endometriosis: First insights into pathogenesis. Journal of Reproductive Immunology. 2014;105:30-33. doi:10.1016/j.jri.2014.06.009
Della Porta M, Danova M. CD44 as a molecular target in advanced cancer: Potential therapeutic strategies. Current Drug Targets. 2010;11(7):813-818. doi:10.2174/138945010791011847
Valencia T, Joseph A, Kachala SS, et al. The impact of stem cells in oral cancer therapy. Current Stem Cell Research & Therapy. 2015;10(2):136-144. doi:10.2174/1574888X10666150202115940
Richards RG, Brandenberger R, O'Connor M, et al. Cancer stem cells in gynaecological cancers. Current Cancer Drug Targets. 2012;12(5):353-361. doi:10.2174/156800912800784909
